Improvement in minimum detectable activity for low energy gamma by optimization in counting geometry

Gamma spectrometry for environmental samples of low specific activities demands low minimum detection levels of measurement. An attempt has been made to lower the gamma detection level of measurement by optimizing the sample geometry, without compromising on the sample size. Gamma energy of 50–200 keV range was chosen for the study, since low energy gamma photons suffer the most self-attenuation within matrix. The simulation study was carried out using MCNP based software “EffCalcMC” for silica matrix and cylindrical geometries. A volume of 250 ml sample geometry of 9 cm diameter is optimized as the best suitable geometry for use, against the in-practice 7 cm diameter geometry of same volume. An increase in efficiency of 10%–23% was observed for the 50–200 keV gamma energy range and a corresponding lower minimum detectable activity of 9%–20% could be achieved for the same

Study of equilibrium status among uranium and thorium series radionuclides in soil samples from Visakhapatnam, India

Surface soil samples from coastal region of Visakhapatnam were analyzed for uranium series and thorium series radionuclides by high-resolution gamma-ray spectrometry. Isotopic ratios of 226Ra/238U and 224Ra/232Th were calculated to investigate the radioactive equilibrium status in the samples. 226Ra/238U and 224Ra/232Th ratios were found to vary from 0.80–1.40 to 0.94–1.40 with mean values of 1.05 and 0.99, respectively. Results showed a prevalent radioactive equilibrium for both uranium and thorium series radionuclides in the surface soil of the study area

Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study

Cardiovascular diseases (CVDs), principally ischemic heart disease (IHD) and stroke, are the leading cause of global mortality and a major contributor to disability. This paper reviews the magnitude of total CVD burden, including 13 underlying causes of cardiovascular death and 9 related risk factors, using estimates from the Global Burden of Disease (GBD) Study 2019. GBD, an ongoing multinational collaboration to provide comparable and consistent estimates of population health over time, used all available population-level data sources on incidence, prevalence, case fatality, mortality, and health risks to produce estimates for 204 countries and territories from 1990 to 2019. Prevalent cases of total CVD nearly doubled from 271 million (95% uncertainty interval [UI]: 257 to 285 million) in 1990 to 523 million (95% UI: 497 to 550 million) in 2019, and the number of CVD deaths steadily increased from 12.1 million (95% UI:11.4 to 12.6 million) in 1990, reaching 18.6 million (95% UI: 17.1 to 19.7 million) in 2019. The global trends for disability-adjusted life years (DALYs) and years of life lost also increased significantly, and years lived with disability doubled from 17.7 million (95% UI: 12.9 to 22.5 million) to 34.4 million (95% UI:24.9 to 43.6 million) over that period. The total number of DALYs due to IHD has risen steadily since 1990, reaching 182 million (95% UI: 170 to 194 million) DALYs, 9.14 million (95% UI: 8.40 to 9.74 million) deaths in the year 2019, and 197 million (95% UI: 178 to 220 million) prevalent cases of IHD in 2019. The total number of DALYs due to stroke has risen steadily since 1990, reaching 143 million (95% UI: 133 to 153 million) DALYs, 6.55 million (95% UI: 6.00 to 7.02 million) deaths in the year 2019, and 101 million (95% UI: 93.2 to 111 million) prevalent cases of stroke in 2019. Cardiovascular diseases remain the leading cause of disease burden in the world. CVD burden continues its decades-long rise for almost all countries outside high-income countries, and alarmingly, the age-standardized rate of CVD has begun to rise in some locations where it was previously declining in high-income countries. There is an urgent need to focus on implementing existing cost-effective policies and interventions if the world is to meet the targets for Sustainable Development Goal 3 and achieve a 30% reduction in premature mortality due to noncommunicable diseases